Melanocortin receptor activation
Also known as: Melanotan I · MT-1 · MT-I · MT-1 Melanotin Receptor Type 1 · α-MSH analogue · Scenesse
The essentials at a glance
Promotes eumelanin production; approval is limited to a rare photosensitivity disorder.
Distinction: Afamelanotide selectively targets the melanocortin-1 receptor and is approved for a rare disorder, unlike the non-selective, unapproved Melanotan II.
The described biological role is well established, or extensive regulator-reviewed human data exist for clearly defined products and uses. This does not automatically transfer to other products or purposes.
Approved for specific uses: Prescription active ingredient for defined indications in at least one jurisdiction; not offered here.
Research questions
This studies how activating melanocortin receptors affects pigmentation or sexual arousal signals, like a switch controlling different body functions depending on the receptor subtype. Skin pigmentation or physiological arousal markers are measured in studies.
This studies how skin pigment cells respond to signals that darken skin, potentially reducing sensitivity to sunlight, similar to how a photograph darkens with more exposure. Researchers typically measure skin pigment levels and light sensitivity in study participants.
This examines effects on hormone axes influencing libido, cycle, or fertility, similar to a feedback loop connecting several glands. Hormone levels and subjective questionnaires are measured in studies.
Simple example
Think of it like a product that has gone through a defined review process, similar to a vehicle that has passed a technical inspection.
Even approval covers only the reviewed indication and dosing regimen and does not guarantee an individual outcome.
Community themes
Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.
Users compare tanning or skin changes after using melanocortin-related substances, often based on shared photos rather than medical examination. Such posts do not establish reviewed safety, especially for unapproved variants.
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
Broader wellbeing impressions such as mood, sleep, and general feeling after using various products are exchanged here, usually without structured tracking. Such general impressions are not a substitute for targeted clinical examination.
Why individual profiles do not contain mixing instructions
Reconstitution depends on the exact product, label, identity, concentration, sterility and stability. Arithmetic examples appear only in the separately labelled community area and are not recommendations.
Reconstitution & quantitiesOpen basics, units and sourcesUse & mixingEvidence boundary
Approval covers only the specific photosensitivity disorder.
No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.
Primary sources
Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.
